Italian API firm Olon acquires Infa Group

Italy-based P&R Group has signed a binding agreement to acquire 100% of the Italian pharmaceutical chemical manufacturer, Infa Group through the P&R subsidiary Olon SpA.

Olon has five manufacturing sites in northern Italy with more than 800 employees while INFA Group, with more than 400 employees, has two manufacturing sites in Italy, Labochim and Sifavitor and one in Spain, Derivados Quimicos. The combined sales turnover will exceed 300 million euros ($335 million) with an extensive product and technology portfolio.

Olon is one of the largest European developers and manufacturers supplying active pharmaceutical ingredients (APIs) for the pharmaceutical industry worldwide both, for generic as well as for contract manufacturing. Olon and Infa will have available about 130 active US Drug Master Files (DMFs) and more than 50 EU Certificates of Suitability (COS) or Compliance with the European Pharmacopoeia (CEP).

The transaction, financial terms of which are not disclosed, will be completed after clearance is received from the Antitrust Authority which is expected in 30-45 days.